NGC Update Service: February 13, 2017

ngc

February 13, 2017

New This Week

Guideline Summaries

American Physical Therapy Association, Neurology Section New Developer

American Society of Clinical Oncology

Withdrawn Guideline Summaries

The guideline summaries listed below have been withdrawn from the NGC Web site because they no longer meet the NGC Inclusion Criteria. See the Guideline Summaries Archive for a complete list of summaries that have been withdrawn from NGC.

AIM Specialty Health

  • Bi-level positive airway pressure (BPAP) devices.

Institute for Clinical Systems Improvement

  • Diagnosis and initial treatment of ischemic stroke.

Announcements

U.S. Food and Drug Administration (FDA) Advisory

February 2, 2017: Chlorhexidine Gluconate: FDA is warning that rare but serious allergic reactions have been reported with the widely used skin antiseptic products containing chlorhexidine gluconate. Although rare, the number of reports of serious allergic reactions to these products has increased over the last several years.

As a result, FDA is requesting the manufacturers of over-the-counter (OTC) antiseptic products containing chlorhexidine gluconate to add a warning about this risk to the Drug Facts labels.

Conference News

Registration is now open for the Evidence-based Guidelines Affecting Policy, Practice and Stakeholders (E-GAPPS III) Conference. It will be held March 20-21, 2017 at The New York Academy of Medicine. The event is sponsored by the Guidelines International Network North America (G-I-N NA) and NYAM's Section on Evidence Based Health Care (SEBHC). The conference is titled "Beyond Implementation: Are Clinical Guidelines Improving Healthcare Quality?"

AHRQ Announces Funding Opportunity for Developing Measures of Shared Decisionmaking

A new funding opportunity announcement from AHRQ solicits applications for research projects to develop, test and evaluate measures of shared decisionmaking for research conducted in clinical settings. Shared decisionmaking is a collaborative process in which patients and members of their clinical team make health care decisions that are informed by scientific evidence as well as patients' values and preferences. Each project is expected to produce valid and reliable measures of shared decisionmaking, along with instructions for implementing the measures and documentation on the development, testing and evaluation of the measures. The maximum cost for each project is $500,000 per year and $1.5 million for up to three years.

Health Awareness Topics: February 2017

How to Participate

Submit Guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines.

Suggest a Guideline for Possible Inclusion: Submit your suggestions for evidence-based clinical practice guidelines that you would like to see included in NGC.

NGC's Sister Resource

Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).